Method development · MSK
HostBio / Comp-MRF
I developed HostBio to estimate interpretable tissue composition from routine CT despite partial-volume mixing and acquisition variability. The framework is implemented for clinical research at MSK and has been evaluated in independent lung cancer cohorts.
1,078 patients · 4 NSCLC cohorts · randomized trial data
Explore HostBio →